Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Neuroactive kynurenines in Lyme borreliosis.

Halperin JJ, Heyes MP.

Neurology. 1992 Jan;42(1):43-50.

PMID:
1531156
2.

Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease.

Heyes MP, Saito K, Crowley JS, Davis LE, Demitrack MA, Der M, Dilling LA, Elia J, Kruesi MJ, Lackner A, et al.

Brain. 1992 Oct;115 ( Pt 5):1249-73.

PMID:
1422788
3.

Relationship of neurologic status in macaques infected with the simian immunodeficiency virus to cerebrospinal fluid quinolinic acid and kynurenic acid.

Heyes MP, Jordan EK, Lee K, Saito K, Frank JA, Snoy PJ, Markey SP, Gravell M.

Brain Res. 1992 Jan 20;570(1-2):237-50.

PMID:
1535532
4.
5.

Inter-relationships between quinolinic acid, neuroactive kynurenines, neopterin and beta 2-microglobulin in cerebrospinal fluid and serum of HIV-1-infected patients.

Heyes MP, Brew BJ, Saito K, Quearry BJ, Price RW, Lee K, Bhalla RB, Der M, Markey SP.

J Neuroimmunol. 1992 Sep;40(1):71-80.

PMID:
1387655
6.

Quinolinic acid in tumors, hemorrhage and bacterial infections of the central nervous system in children.

Heyes MP, Saito K, Milstien S, Schiff SJ.

J Neurol Sci. 1995 Nov;133(1-2):112-8.

PMID:
8583213
7.

Sustained increases in cerebrospinal fluid quinolinic acid concentrations in rhesus macaques (Macaca mulatta) naturally infected with simian retrovirus type-D.

Heyes MP, Gravell M, London WT, Eckhaus M, Vickers JH, Yergey JA, April M, Blackmore D, Markey SP.

Brain Res. 1990 Oct 29;531(1-2):148-58.

PMID:
1963097
9.

Quinolinic acid in cerebrospinal fluid and serum in HIV-1 infection: relationship to clinical and neurological status.

Heyes MP, Brew BJ, Martin A, Price RW, Salazar AM, Sidtis JJ, Yergey JA, Mouradian MM, Sadler AE, Keilp J, et al.

Ann Neurol. 1991 Feb;29(2):202-9.

PMID:
1826418
11.

Lyme borreliosis-associated encephalopathy.

Halperin JJ, Krupp LB, Golightly MG, Volkman DJ.

Neurology. 1990 Sep;40(9):1340-3.

PMID:
2392213
12.

The 1993 Upjohn Award Lecture. Quinolinic acid induced brain neurotransmitter deficits: modulation by endogenous excitotoxin antagonists.

Jhamandas KH, Boegman RJ, Beninger RJ.

Can J Physiol Pharmacol. 1994 Dec;72(12):1473-82. Review.

PMID:
7736338
13.

Central nervous system abnormalities in Lyme neuroborreliosis.

Halperin JJ, Volkman DJ, Wu P.

Neurology. 1991 Oct;41(10):1571-82.

PMID:
1922798
14.

PCR detection of Borrelia burgdorferi DNA in cerebrospinal fluid of Lyme neuroborreliosis patients.

Keller TL, Halperin JJ, Whitman M.

Neurology. 1992 Jan;42(1):32-42.

PMID:
1734321
15.
16.

Neuropharmacology of quinolinic and kynurenic acids.

Stone TW.

Pharmacol Rev. 1993 Sep;45(3):309-79. Review.

PMID:
8248282
17.

Concentrations of macrophage inflammatory proteins MIP-1alpha and MIP-1beta and interleukin 8 (il-8) in lyme borreliosis.

Grygorczuk S, Pancewicz S, Zajkowska J, Kondrusik M, RwierzbiƄska R, Hermanowska-Szpakowicz T.

Infection. 2004 Dec;32(6):350-5.

PMID:
15597225
18.
19.

Pathogenesis of neuroborreliosis--lessons from a monkey model.

Pachner AR, Schaefer H, Amemiya K, Cadavid D, Zhang WF, Reddy K, O'Neill T.

Wien Klin Wochenschr. 1998 Dec 23;110(24):870-3. Review.

PMID:
10048168
20.

Neopterin production and tryptophan degradation in acute Lyme neuroborreliosis versus late Lyme encephalopathy.

Gasse T, Murr C, Meyersbach P, Schmutzhard E, Wachter H, Fuchs D.

Eur J Clin Chem Clin Biochem. 1994 Sep;32(9):685-9.

PMID:
7865624

Supplemental Content

Support Center